Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stonepine Capital Management, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dennis Langer - $129K in QNRX purchases and sales in the last 12 months
- Michael Myers - $100K in QNRX purchases and sales in the last 12 months
- Denise P. Carter - $100K in QNRX purchases and sales in the last 12 months
- Sally Bridget Lawlor - $50K in QNRX purchases and sales in the last 12 months
- Anthony James Culverwell - $30K in QNRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Stonepine Capital Management, LLC?
Stonepine Capital Management, LLC is an investment firm, tracked as 10% Owner of Quoin Pharmaceuticals, Ltd. (QNRX). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Stonepine Capital Management, LLC last file a Form 4?
The only primary Form 4 on record is dated 31 March 2026.